Similar articles

• [Blockade of 5-HT2 receptors as a mechanism of antihypertensive action of ketanserin].

  Prostran M. Prostran M. Srp Arh Celok Lek. 1994 Mar-Apr;122(3-4):99-102. Srp Arh Celok Lek. 1994. PMID: 17972821 Review. Serbian.
• Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT(2A) receptors.

  Shen FM, Wang J, Ni CR, Yu JG, Wang WZ, Su DF. Shen FM, et al. Clin Exp Pharmacol Physiol. 2007 Aug;34(8):702-7. doi: 10.1111/j.1440-1681.2007.04626.x. Clin Exp Pharmacol Physiol. 2007. PMID: 17600544
• [Clinical application of serotonin antagonists in the treatment of hypertension].

  Deguchi F, Saito T, Inagaki Y. Deguchi F, et al. Nihon Rinsho. 1989 Sep;47(9):2058-63. Nihon Rinsho. 1989. PMID: 2593279 Japanese. No abstract available.
• Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease.

  Podoleanu D, Cotoi S. Podoleanu D, et al. Rom J Intern Med. 1996 Jan-Jun;34(1-2):49-54. Rom J Intern Med. 1996. PMID: 8908630
• [A new antihypertensive: ketanserin].

  Salvini P. Salvini P. Riv Eur Sci Med Farmacol. 1989 Feb;11(1):77-84. Riv Eur Sci Med Farmacol. 1989. PMID: 2678304 Review. Italian.